The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, November 17, 2017
Amgen announced that the ENBREL Mini with AutoTouch is now available in the United States.
read more
Monday, November 20, 2017
Kaléo announced the FDA has approved its supplemental New Drug Application sNDA for AUVI-Q 0.1 mg.
read more
Wednesday, November 29, 2017
Ferring Pharmaceuticals and Aché Laboratórios Farmacêuticos announced their joint nanotechnology center in São Paulo, Brazil.
read more
Thursday, November 30, 2017
Cordis and Medinol announced the FDA approved the EluNIR drug-eluting stent for the treatment of patients with narrowing or blockages to their ...
read more
Monday, December 04, 2017
Mylan and Aspen announced the U.S. launch of Myleran Injection, 60 mg/10 mL (6 mg/mL) Single-dose Vial, a generic version of Busulfex Injection.
read more
Tuesday, December 05, 2017
Eli Lilly and Company announced the FDA has approved Taltz injection 80 mg/mL for the treatment of adults with active psoriatic arthritis.
read more
Wednesday, December 06, 2017
OZEMPIC is administered once weekly, on the same day each week, and can be taken any time of the day, with or without meals.
read more
Wednesday, December 06, 2017
Eli Lilly and Company has dosed the first patient with type 1 diabetes in a feasibility study to evaluate the functionality and safety of an AID ...
read more
Thursday, December 07, 2017
Alcyone Lifesciences announced the first successful clinical use in a pediatric patient of its Alcyone MEMS Cannula platform in a Phase 1 study for a ...
read more
Monday, December 11, 2017
Eli Lilly and Company announced the FDA has accepted a BLA to review galcanezumab for the prevention of migraine in adults.
read more
Tuesday, December 12, 2017
The PhRMA announced a new multi-year, multimillion dollar initiative to address the opioid crisis.
read more
Thursday, December 14, 2017
Medimetriks announced the U.S. Food and Drug Administration (FDA) approved Xepi Cream, 1%, a new chemical entity for the treatment of impetigo.
read more
Thursday, December 14, 2017
Mylan announced the PTAB has instituted IPR proceedings on all claims against two Orange Book-listed patents, U.S. Patent Nos. 7,476,652 and 7,713,930...
read more
Wednesday, December 20, 2017
Evox has entered into a research collaboration with Boehringer Ingelheim to investigate exosome-mediated delivery of RNAs with high medical relevance ...
read more
Wednesday, December 20, 2017
Prescient Surgical announced the FDA has cleared the CleanCision Wound Retraction and Protection System for commercialization in the United States.
read more